Methods for assessing risk of developing a viral disease using a genetic test

US11913074B2 · kind B2 · utility

Assignees

• PML Screening, LLC · US
• UNIVERSITE PARIS-SACLAY
• ASSISTANCE PUBLIQUE—HÔPITAUX DE PARIS (APHP) · FR
• Institut National de la Sante et de la Recherche Medicale (INSERM) · FR

Inventors

• Eli Hatchwell · Smithtown, US
• Peggy S. Eis · Fitchburg, US
• Edward B. Smith, III · Seattle, US
• Yassine Taoufik · Paris, FR

Key dates

• Filing date: Mar 17, 2023
• Grant date: Feb 27, 2024
• Expiry date: Mar 17, 2043

Classification

• Technology area (CPC Y): Emerging Cross-Sectional Technologies
• CPC primary: Y02A50/30
• WIPO field: Biotechnology
• WIPO sector: Chemistry

Abstract

This document provides methods and materials related to treating a disease. For example, this document provides methods for treating a subject's disease based on identifying the risk of progressive multifocal leukoencephalopathy PML using a genetic test.